Literature DB >> 27358636

Diagnostic value of diffusion weighted MRI and ADC in differential diagnosis of cavernous hemangioma of the liver.

Ozlem Tokgoz1, Ebru Unlu2, Ilker Unal3, Ismail Serifoglu4, Ilker Oz4, Elif Aktas1, Emrah Caglar4.   

Abstract

AIMS: To investigate the use of diffusion weighted magnetic resonance imaging (DWI) and the apparent diffusion coefficient (ADC) values in the diagnosis of hemangioma.
MATERIALS AND METHODS: The study population consisted of 72 patients with liver masses larger than 1 cm (72 focal lesions). DWI examination with a b value of 600 s/mm2 was carried out for all patients. After DWI examination, an ADC map was created and ADC values were measured for 72 liver masses and normal liver tissue (control group). The average ADC values of normal liver tissue and focal liver lesions, the "cut-off" ADC values, and the diagnostic sensitivity and specificity of the ADC map in diagnosing hemangioma, benign and malignant lesions were researched.
RESULTS: Of the 72 liver masses, 51 were benign and 21 were malignant. Benign lesions comprised 38 hemangiomas and 13 simple cysts. Malignant lesions comprised 9 hepatocellular carcinomas, and 12 metastases. The highest ADC values were measured for cysts (3.782±0.53×10(-3) mm(2)/s) and hemangiomas (2.705±0.63×10(-3) mm(2)/s). The average ADC value of hemangiomas was significantly higher than malignant lesions and the normal control group (p<0.001). The average ADC value of cysts were significantly higher when compared to hemangiomas and normal control group (p<0.001). To distinguish hemangiomas from malignant liver lesions, the "cut-off" ADC value of 1.800×10(-3) mm(2)/s had a sensitivity of 97.4% and a specificity of 90.9%. To distinguish hemangioma from normal liver parenchyma the "cut-off" value of 1.858×10(-3) mm(2)/s had a sensitivity of 97.4% and a specificity of 95.7%. To distinguish benign liver lesions from malignant liver lesions the "cut-off" value of 1.800×10(-3) mm(2)/s had a sensitivity of 96.1% and a specificity of 90.0%.
CONCLUSION: DWI and quantitative measurement of ADC values can be used in differential diagnosis of benign and malignant liver lesions and also in the diagnosis and differentiation of hemangiomas. When dynamic examination cannot distinguish cases with vascular metastasis and lesions from hemangioma, DWI and ADC values can be useful in the primary diagnosis and differential diagnosis. The technique does not require contrast material, so it can safely be used in patients with renal failure.

Entities:  

Keywords:  Liver; apparent diffusion coefficient; diffusion weighted magnetic resonance imaging; hemangioma

Mesh:

Year:  2016        PMID: 27358636      PMCID: PMC4915395          DOI: 10.4314/ahs.v16i1.30

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  25 in total

1.  Diffusion-tensor MR imaging at 1.5 and 3.0 T: initial observations.

Authors:  S Hunsche; M E Moseley; P Stoeter; M Hedehus
Journal:  Radiology       Date:  2001-11       Impact factor: 11.105

2.  Diffusion tensor MRI of the human kidney.

Authors:  M Ries; R A Jones; F Basseau; C T Moonen; N Grenier
Journal:  J Magn Reson Imaging       Date:  2001-07       Impact factor: 4.813

3.  Single-shot diffusion-weighted echo-planar imaging of normal and cirrhotic livers using a phased-array multicoil.

Authors:  F Ståhlberg; S Brockstedt; C Thomsen; R Wirestam
Journal:  Acta Radiol       Date:  1999-05       Impact factor: 1.990

4.  ADC measurement of abdominal organs and lesions using parallel imaging technique.

Authors:  Takeshi Yoshikawa; Hideaki Kawamitsu; Donald G Mitchell; Yoshiharu Ohno; Yonson Ku; Yasushi Seo; Masahiko Fujii; Kazuro Sugimura
Journal:  AJR Am J Roentgenol       Date:  2006-12       Impact factor: 3.959

5.  Single-shot diffusion-weighted echo-planar imaging of normal and cirrhotic livers using a phased-array multicoil.

Authors:  Y Amano; T Kumazaki; M Ishihara
Journal:  Acta Radiol       Date:  1998-07       Impact factor: 1.990

6.  Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging.

Authors:  D Le Bihan; E Breton; D Lallemand; M L Aubin; J Vignaud; M Laval-Jeantet
Journal:  Radiology       Date:  1988-08       Impact factor: 11.105

7.  Diffusion-weighted single-shot echoplanar MR imaging for liver disease.

Authors:  T Kim; T Murakami; S Takahashi; M Hori; K Tsuda; H Nakamura
Journal:  AJR Am J Roentgenol       Date:  1999-08       Impact factor: 3.959

8.  Evaluation of hepatic lesions and hepatic parenchyma using diffusion-weighted reordered turboFLASH magnetic resonance images.

Authors:  Takao Moteki; Hiroyuki Horikoshi; Nariyuki Oya; Jun Aoki; Keigo Endo
Journal:  J Magn Reson Imaging       Date:  2002-05       Impact factor: 4.813

9.  Measurement of the apparent diffusion coefficient in diffuse renal disease by diffusion-weighted echo-planar MR imaging.

Authors:  T Namimoto; Y Yamashita; K Mitsuzaki; Y Nakayama; Y Tang; M Takahashi
Journal:  J Magn Reson Imaging       Date:  1999-06       Impact factor: 4.813

10.  Fast magnetic resonance diffusion-weighted imaging of acute human stroke.

Authors:  S Warach; D Chien; W Li; M Ronthal; R R Edelman
Journal:  Neurology       Date:  1992-09       Impact factor: 9.910

View more
  3 in total

1.  Diffusion Kurtosis MR Imaging versus Conventional Diffusion-Weighted Imaging for Distinguishing Hepatocellular Carcinoma from Benign Hepatic Nodules.

Authors:  Yingmei Jia; Huasong Cai; Meng Wang; Yanji Luo; Ling Xu; Zhi Dong; Xu Yan; Zi-Ping Li; Shi-Ting Feng
Journal:  Contrast Media Mol Imaging       Date:  2019-07-17       Impact factor: 3.161

2.  Evaluation of ADCratio on liver MRI diffusion to discriminate benign versus malignant solid liver lesions.

Authors:  Tarun Pankaj Jain; Wen Ter Kan; Sean Edward; Helen Fernon; Renuvathy Kansan Naider
Journal:  Eur J Radiol Open       Date:  2018-11-15

3.  Evaluation of the Effect of Patient Preparation Using Castor Oil on ADC Value of Focal Liver Lesion.

Authors:  Kawa Abdulla Mahmood; Rezheen Jamal Rashid; Salah Mohammed Fateh; Naser Abdullah Mohammed
Journal:  Int J Gen Med       Date:  2021-02-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.